Results 101 to 110 of about 6,454 (219)

Tirzepatide: Does the Evidence to Date Show Potential for the Treatment of Early Stage Type 2 Diabetes?

open access: yesTherapeutics and Clinical Risk Management, 2022
Tanzila S Razzaki,* Alyson Weiner,* Alpana P Shukla Comprehensive Weight Control Center, Division of Endocrinology, Diabetes, and Metabolism Weill Cornell Medicine, New York, NY, USA*These authors contributed equally to this ...
Razzaki TS, Weiner A, Shukla AP
doaj  

TARGETING MULTIPLE PATHWAYS WITH ONE MOLECULE: THE THERAPEUTIC VERSATILITY OF TIRZEPATIDE [PDF]

open access: yes
Tirzepatide is a novel dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors that offers promising therapeutic potential beyond glycemic control.
Adam Żuczek   +9 more
core   +2 more sources

Multidisciplinary Therapy to Target Obesity and Its Complications in Adult Population: A Narrative Review

open access: yesObesity Reviews, EarlyView.
ABSTRACT Obesity as a chronic and multifactorial disease requires a multidisciplinary team acting together in a holistic multitarget intervention. Multidisciplinary therapy targeting obesity and its complications includes physical exercise, nutritional, and behavior counseling.
Ana Raimunda Dâmaso   +7 more
wiley   +1 more source

Engineering Marker‐Free Lettuce Chloroplast Genome to Express Functional Glucagon‐Like Peptide‐1 Receptor Agonists Exenatide and Lixisenatide

open access: yesPlant Biotechnology Journal, EarlyView.
Engineering of marker‐free lettuce chloroplast genome to express CTB‐Exenatide and CTB‐Lixisenatide for oral delivery. Upper panel: Chemically synthesised exenatide or lixisenatide require expensive production, purification, refrigeration and invasive delivery methods.
Rahul Singh, Henry Daniell
wiley   +1 more source

Perspectives on weight control in diabetes – Tirzepatide [PDF]

open access: yes, 2023
Pavo Imre   +3 more
core   +1 more source

Tirzepatide, A New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Narrative Review [PDF]

open access: yes
This review presents an in-depth exploration of the evolving landscape in managing type 2 diabetes mellitus (T2DM), emphasizing the substantial impact of obesity on its prevalence.
Madhvi Ghadge, Aarti, Ashwani Kumar, Ishu, Aashutosh Sinwal, Nisha
core   +2 more sources

Effects of GLP‐1 Receptor Agonists on Hair Loss and Regrowth: A Systematic Review

open access: yes
International Journal of Dermatology, EarlyView.
Miranda K. Branyiczky   +4 more
wiley   +1 more source

De gustibus est disputandum: The role of agricultural and applied economists in an era of behavior change initiatives and endogenous preferences

open access: yesAmerican Journal of Agricultural Economics, Volume 108, Issue 2, Page 429-442, March 2026.
Abstract Popular society increasingly questions preferences that drive many resource allocations and production decisions, with many groups actively seeking to alter those preferences to achieve changes to resource use. Agricultural and applied economists, who are already equipped with excellent technical skills to undertake consumer preference and ...
Brian E. Roe
wiley   +1 more source

Tirzepatide‐induced body composition changes: Implications from the SURPASS‐3 MRI substudy

open access: yes
Journal of Diabetes Investigation, EarlyView.
I‐Weng Yen, Hung‐Yuan Li
wiley   +1 more source

Improvement of Analysis and Transferability in Peptide Purification: From HPLC to FPLC and Back Again

open access: yesJournal of Peptide Science, Volume 32, Issue 3, March 2026.
A predictive workflow enables accurate transfer from analytical HPLC to preparative FPLC for peptide purification. Systematic evaluation of key chromatographic parameters identified particle size, flow optimization and modifier choice as critical for selectivity and resolution. A correction model minimized elution transfer errors from −17% to less than
Alessandro Streuli   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy